- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tennessee Governor Calls Fed Review of Medicaid Funding "Heavy-Handed"
The federal government's review of how much money it spends to help pay for the hospital costs of low-income people in Tennessee and other states that didn't expand Medicaid feels like a threat to Governor Bill Haslam.
The federal government's review of how much money it spends to help pay for the hospital costs of low-income people in Tennessee and other states that didn't expand Medicaid feels like a threat to Governor Bill Haslam.
"The way they're approaching this feels awfully heavy handed: OK, well if you don't do that, then we're going to restrict the pool of money that we give you for indigent care," Gov Haslam told reporters Thursday.
Federal officials recently reached out to several states about reducing the amount of federal money that goes toward uncompensated care, or care provided to uninsured people who can't pay for it. The officials also contacted Arizona, California, Florida, Hawaii, Kansas, Massachusetts, New Mexico, and Texas. Florida, Kansas, Texas, and Tennessee have not expanded Medicaid.
Read more at The Tennessean: http://tnne.ws/1FnZr95
Review Emphasizes Potential Infection Risks With BTK Inhibitors
November 2nd 2024Although Bruton tyrosine kinase (BTK) inhibitor monotherapy in chronic lymphocytic leukemia (CLL) has been a game-changer, patients have significantly increased risks of infection, especially in the upper respiratory tract.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
PAH Treatment Outcomes Similar Regardless of Diagnosis Time
November 1st 2024The study findings underscore the importance of early initiation of macitentan and tadalafil among patients who have pulmonary arterial hypertension (PAH), and represent a shift in understanding of prognosis based on diagnosis timing.
Read More
